DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 53 filers reported holding DESIGN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $22,050,000 | +9.2% | 3,500,000 | 0.0% | 0.30% | 0.0% |
| Q1 2023 | $20,195,000 | -13.4% | 3,500,000 | +54.0% | 0.30% | -14.1% |
| Q4 2022 | $23,312,998 | -37.3% | 2,272,222 | +2.3% | 0.35% | -49.3% |
| Q3 2022 | $37,156,000 | +19.4% | 2,222,222 | 0.0% | 0.69% | +11.5% |
| Q2 2022 | $31,111,000 | -13.3% | 2,222,222 | 0.0% | 0.62% | -6.1% |
| Q1 2022 | $35,889,000 | +2.5% | 2,222,222 | +35.8% | 0.66% | +9.9% |
| Q4 2021 | $35,029,000 | +62.4% | 1,636,100 | +11.4% | 0.60% | +75.8% |
| Q3 2021 | $21,570,000 | -18.3% | 1,468,318 | 0.0% | 0.34% | -26.1% |
| Q2 2021 | $26,410,000 | -33.5% | 1,468,318 | 0.0% | 0.46% | -33.1% |
| Q1 2021 | $39,702,000 | – | 1,468,318 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 5,364,850 | $78,810,000 | 3.20% |
| Logos Global Management LP | 2,772,501 | $40,728,000 | 2.94% |
| EcoR1 Capital, LLC | 1,863,098 | $27,369,000 | 0.95% |
| RA Capital Management | 2,186,636 | $32,122,000 | 0.44% |
| Vivo Capital, LLC | 530,991 | $7,800,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,468,318 | $21,570,000 | 0.34% |
| Artal Group S.A. | 400,000 | $5,876,000 | 0.13% |
| Rock Springs Capital Management LP | 334,050 | $4,907,000 | 0.10% |
| Baker Brothers Advisors | 1,436,636 | $21,104,000 | 0.09% |
| Eventide Asset Management | 400,000 | $5,876,000 | 0.08% |